Thrombocytosis: an underused risk marker of cancer in ...

Our team has identified this as being relevant in lung, colon, ovary, oesophago-gastric, bladder and pancreas cancers. Together, these six cancer sites suggest that the risk of an underlying cancer in a patient with thrombocytosis exceeds 4% and may be as high as 10%. Such a figure would make a very important contribution to cancer diagnosis: a ... ................
................